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Variations in target volume position between and during treatment fractions can lead to measurable
differences in the dose distribution delivered to each patient. Current methods to estimate the
ongoing cumulative delivered dose distribution make idealized assumptions about individual pa-
tient motion based on average motions observed in a population of patients. In the delivery of
intensity modulated radiation therapy IMRT with a multi-leaf collimator MLC, errors are intro-
duced in both the implementation and delivery processes. In addition, target motion and MLC
motion can lead to dosimetric errors from interplay effects. All of these effects may be of clinical
importance. Here we present a method to compute delivered dose distributions for each treatment
beam and fraction, which explicitly incorporates synchronized real-time patient motion data and
real-time fluence and machine configuration data. This synchronized dynamic dose reconstruction
method properly accounts for the two primary classes of errors that arise from delivering IMRT
with an MLC: a Interplay errors between target volume motion and MLC motion, and b Imple-
mentation errors, such as dropped segments, dose over/under shoot, faulty leaf motors, tongue-and-
groove effect, rounded leaf ends, and communications delays. These reconstructed dose fractions
can then be combined to produce high-quality determinations of the dose distribution
actually received to date, from which individualized adaptive treatment strategies can be
determined. © 2007 American Association of Physicists in Medicine. DOI: 10.1118/1.2388157Key words: Monte Carlo, delivered dose, intra-fraction motion, real-time trackingI. INTRODUCTION
Two primary classes of errors arise from delivering intensity
modulated radiation therapy IMRT with a multi-leaf colli-
mator MLC: a Interplay errors between target volume mo-
tion and MLC motion, and b Implementation errors, such
as dropped segments, dose over/under shoot, slow leaves,
tongue-and-groove effect, rounded leaf ends, and communi-
cations delays. For purposes of this work, interplay errors are
considered to be dosimetric errors that arise due to variations
in the relative motions of the MLC leaves and the patient
anatomy, from those included in the treatment planning pro-
cess. It has been shown that interplay effects between mov-
ing MLC leaves, and the moving target volume, lead to do-
simetric errors of over 100% in a given fraction.1 The
magnitude of these errors depends on the relative orientation
of the leaf and organ motion, the characteristic frequency of
motion and their amplitudes.1 This effect has been shown
experimentally in several intra-fraction motion studies. One
study,2 of clinical head and neck cases, showed deviations as
large as 20% compared to static measurements. In another
phantom study,3 variations as large as 30% were observed in
one fraction, and variations as large as 18% were observed
with five super-imposed beams. Consequently, many pos-
sible scenarios can lead to measurable dosimetric errors in
the implementation and delivery of IMRT.
The majority of IMRT treatments are delivered using a
multi-leaf collimator. Leaf sequencing algorithms are in-
tended to determine the leaf trajectories that will most accu-
rately reproduce the desired fluence pattern during
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must make assumptions. For example, due to transmission, it
is impossible to create a sequence that will deliver zero flu-
ence to any given beamlet, which may lead to dosimetric
errors up to 10%, relative to the maximum beamlet dose. In
addition, some algorithms do not correct for the tongue-and-
groove effect, which may cause dosimetric errors of approxi-
mately 15%.12,15–19
It has also been shown that some leaf sequences may lead
to dosimetric errors due to hardware and software delivery
constraints. For example, communications delays in the
MLC control system and inappropriate leaf position toler-
ance settings may lead to hundreds of beam interruptions.9
This has been shown to lead to 10% dose discrepancies and
unpredictable delivery times.9,20 The communications delay
also leads to dose overshoot on the first segment and under-
shoot on the last segment.21 The communications delay is
related to the operating frequency of the MLC controller
20 Hz on the Varian Millennium MLC Varian Medical Sys-
tems, Palo Alto, CA which determines the temporal reso-
lution for sampling the leaf trajectories. Leaf sequencing al-
gorithms that do not include these effects may create leaf
sequences that attempt to deliver too many dose segments in
a very short time. This can cause some dose segments to be
omitted during delivery.22 There are also reports of leaves
moving while dose is being delivered in step-and-shoot
IMRT.23 This is typically caused by a large leaf position
tolerance and can lead to changes in dose at beamlet edges.
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treatment, a complete knowledge of the cumulative dose de-
livered to date is needed. Thus Dynamic Dose Reconstruc-
tion, based on synchronized real-time target volume and ma-
chine motion data, is needed to make dynamic treatment
refinements as effective as initially envisioned. It is instruc-
tive to review some of the methods that have sought to in-
clude patient motion in treatment planning. Because the pa-
tient’s anatomy varies from fraction to fraction, the
cumulative dose after any given fraction is different from
that determined during treatment planning on a static com-
puted tomography CT patient model. Many techniques
have been developed to estimate the cumulative dose-
delivered-to-date for a given patient.24 These typically in-
volve replanning and summing the patient’s individual treat-
ment fractions to account for positional variations in the
target volume determined before each treatment fraction. In
replanning these fractions, differing levels of sophistication
are used in mapping the variable pre-fraction anatomy geom-
etry back to the reference geometry used for the initial treat-
ment planning. In some cases, the pre-treatment planning CT
model is simply translated to correct for target volume shifts,
while in other cases, image warping is used to map pre-
fraction cone beam computed tomography CBCT models
back to the pre-treatment planning CT reference
geometry.24,25
Intra-fraction motion is typically included via several
computational methods. In some cases the anticipated
breathing motion is convolved with the dose distribution, or
time-weighted variations of the anticipated geometries are
planned and summed.26–33 These idealized models of the
intra-fraction motion assume that the amplitude, offset, fre-
quency and functional form are constant for the entire course
of therapy.3,34 In addition, values are typically chosen as av-
erage values for a population of patients instead of using
values for that specific patient. Consequently, deviations in at
least one of these parameters are likely to be common.
While these techniques are an improvement over conven-
tional treatment planning on static CT models, they have
several inherent limitations. Assumptions are made about the
amplitude, frequency, and functional form of the motion so
that probability distribution functions can be
estimated.27,28,30,35–37 These are assumed to be constant for
every fraction of treatment, though a recent study shows that
there are significant variations in the mean position, ampli-
tude and period from one breathing cycle to the next.38 Fur-
thermore, in the case of dynamic IMRT delivery with a
multi-leaf collimator MLC, dose calculation algorithms
generally assume that there are no interplay effects between
the motion of the MLC leaves and the motion of the target
volume. However, several groups are investigating real-time
modification of leaf trajectories during dynamic IMRT deliv-
ery to compensate for target volume motion.2,39–41 This tech-
nique has the goal of significantly reducing interplay effects,
without increasing treatment times as would happen with
beam gating.
Studies have also been conducted to measure the effects
of intra-fraction motion and their cumulative effect over
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of simulations of idealized intra-fraction motion,34 and con-
sequently, use the same simplifying assumptions about pa-
tient motion in the design of the experiments. These experi-
ments use sinusoidal motions with 1 cm amplitude that begin
at random or offset phases, with periods of 4–5 s. Because
the expectation value of the sine function is zero, and the
dose gradients at beam edges associated with three-
dimensional cathode ray tube 3DCRT and IMRT are
roughly 0.4 cm, one expects the dose variations to become
small when averaging over roughly five or more initial
phases, as seen in the measurements3 and simulations.34,42,43
While the initial justification of using a sine function was
that irregular respiratory motion of patients could always be
decomposed into sine waves by Fourier methods, this detail
has largely been overlooked. No simulations or measure-
ments on the effects of nonideal intra-fraction motion were
found in the literature, using motions that include drifts,
changes in amplitude, or changes in period, as are commonly
found in measured patient data.
While conformal delivery of high doses has been shown
to be beneficial in many treatment sites, its effectiveness is
limited by target motion, MLC motion interplay and imple-
mentation effects. Previous offline adaptive protocols suf-
fered from the difficulty of obtaining patient specific infor-
mation and the necessity of making simplifying statistical
assumptions about the distribution of the measured variations
in position. Likewise, current methods of including motion
in treatment planning calculations make similar simplifying
assumptions about the nature of the motion and ignore inter-
play and delivery effects that are assumed to average out
over the course of treatment.
In a true accounting for inter- and intra-fraction motion
and delivery interplay effects, dose accumulation techniques
must account for real-time spatial and temporal changes in
the intra-fraction motion of the patient and in the MLC
leaves in a synchronized manner. Synchronizing real-time
motion and fluence data will yield delivered dose reconstruc-
tion data that accurately reflect the following effects: inter-
and intra-fraction setup errors and motion, motion interplay
effects, temporal interplay effects during beam holds,
tongue-and-groove effect, dropped segments, dose over- and
undershoot, and leaf position errors. These effects will be
accurately taken into account, without making simplifying
assumptions about target volume motion or delivery effects.
Consequently, by synchronizing this information to the be-
ginning of the fraction, a complete real-time record of the
fluence patterns delivered to the time-varying target volume
position is obtained for every beam of each fraction. Thus,
synchronized dynamic dose reconstruction is a tool that will
allow cumulative deviations from the treatment plan to be
assessed over the course of treatment, so that corrective ac-
tion may be taken as necessary to ensure the prescribed dose
distribution is delivered as accurately as possible.
II. MATERIALS AND METHODS
In the following sections, we will describe the real-timefluence and machine configuration data, and the real-time
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chronized dynamic dose reconstruction method. The calcula-
tion method itself is then described, followed by the proof-
of-principle measurements and calculations.
A. Real-time tracking of the treatment machine MLC
In order to determine the cumulative dose delivered to the
moving patient geometry, we must also know the shape of
the fluence pattern delivered as a function of time over the
course of each IMRT field delivered during a treatment frac-
tion. On Varian treatment machines, this information is re-
corded in the DynaLog files.9,44–48 These files contain the
leaf positions and beam state on/off at 50 ms intervals for a
given IMRT treatment field.
Previous studies have validated the accuracy of the infor-
mation contained in these files and found the reported leaf
positions to agree with measurements to within the measure-
ment uncertainty ±0.1 cm at isocenter, and the delivered
MU per segment to agree with measurements to within
2%.46,47 In addition, these studies have shown that the data in
the DynaLog files accurately reflects deviations from ideal-
ized behavior, such as dropped segments, first segment dose
overshoot and last segment dose undershoot, and leaf motion
during step-and-shoot IMRT delivery.45
B. Measuring real-time target volume motion with
wireless transponders
Several technologies exist for real-time tracking of intra-
fraction motion including ultrasound, fluoroscopy, and elec-
tromagnetic tracking. In this work, we used an electromag-
netic tracking system Calypso Medical Technologies, Inc..
The components, capabilities and accuracy of this system
have been previously reported49–51 and are summarized here
for convenience. The system uses three implantable wireless
transponders, continuously tracked during therapy using an
external electromagnetic array, to establish target position ten
times per second. The system has been shown to have sub-
millimeter accuracy throughout the active tracking volume,
and readout precision ranging from 0.001 cm at 8 cm from
the array, to 0.04 cm at 27 cm from the array. In-vault ex-
periments demonstrated submillimeter accuracy in measur-
ing known offsets of transponders in a phantom. Comparison
of radiographic to electromagnetic localization, both in phan-
toms and in patients, demonstrated that the system is capable
of accuracy similar to that from orthogonal diagnostic radio-
graphs. Experiments to test the accuracy of moving transpon-
ders showed that the 3D rms positional error was less than
0.054 cm for velocities up to 3 cm/s.
C. Real-time target volume tracking data from initial
clinical studies
Initial clinical studies of the Calypso system were con-
ducted to evaluate positional stability and implant experience
with implanted transponders.50 Inter-transponder distances
were typically stable by day four postimplant but at the latest
by day 14, when the CT planning simulation was performed.
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from day 14 through fraction 20 in 20 patients was 0.08 cm
range 0.02–0.19 cm.
In initial clinical studies, 11 of 20 patients participated in
an 8 min session in which the transponders were tracked
continuously at 10 Hz. Intra-treatment movements were ob-
served on time scales inconsistent with breathing i.e., not
periodic with a roughly 4–5 s period and with magnitudes
ranging up to 1.3 cm. Figure 1 shows two example plots of
prostate motion monitored at 10 Hz using this prototype sys-
tem. Figure 1a shows a slow, continuous trend in motion
along these axes over the entire observation time, while the
Fig. 1b shows movement of the prostate in the anterior-
posterior and inferior-superior directions early during the
monitoring period. High frequency components in these
plots indicate the quiet breathing pattern of these supine pa-
tients. Overall, after initial positioning, the average prostate
movement seen across 11 patients during the observation
time after initial positioning ranged from 0.13 to 0.58 cm
average 0.31 cm, with maximum per-patient temporal ex-
cursions from 0.19 up to 1.20 cm.
This system is well suited for measuring translations and
rotations about the center of the implanted Beacons and in
rigid geometries. The use of this technology, in conjunction
with cone beam CT and other technologies, in deforming
geometries is briefly discussed in Section IV D. The Time-
Dependent Geometric Patient Model.
D. Monte Carlo simulations
In this section, we present the synchronized dynamic dose
reconstruction method, followed by the source model and
FIG. 1. Data from two patients who were monitored at 10 Hz, for 8 min
each, using the Calypso® 4D localization system. Figure a shows a maxi-
mum deviation in any direction of less than 0.3 cm, which is typical for nine
of the 11 patients monitored, while b shows much larger deviations, which
were seen in two patients.MLC model implemented within the Monte Carlo algorithm.
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method
This method is implemented using the dose planning
method DPM Monte Carlo code developed by Bielajew
and collaborators52 for radiation therapy treatment planning
calculations. The code has been validated,53–56 integrated
within our in-house treatment planning system, UMPlan,57,58
and preliminary clinical treatment planning studies
conducted.28,57 The method is illustrated in Fig. 2 and imple-
mented as follows. A time not a monitor unit fraction dur-
ing a beam delivery was randomly generated from a uniform
distribution and compared to the “beam-on” flag at the cor-
responding time in the DynaLog files. If the beam was on, a
photon was sampled from a pre-calculated phase-space plane
located above the jaws. The MLC leaf positions at that time
are also determined from the DynaLog files, and the phan-
tom position or target volume position determined from the
FIG. 2. Flow chart for the SDDR method implemented in the DPM Monte
Carlo dose calculation algorithm.measured motion profile. The photon is then propagated
Medical Physics, Vol. 34, No. 1, January 2007through that instance of the MLC and patient geometry. This
process is repeated until the desired level of dosimetric un-
certainty is achieved.
The uniform time sampling technique allows this algo-
rithm to account for periods when the beam is off, and still
advance target volume motion without depositing dose. This
allows spatial and temporal interplay effects to be included
in the dose calculation, as well as all delivery related issues
recorded in the DynaLog files.
2. Source model
A source model of a Varian 2100EX linear accelerator and
the 120-leaf multi-leaf collimator MLC has been developed
for simulations in this study.59 The model is based on
BEAMnrc60 simulations of the patient-independent compo-
nents, the target, primary collimator, flattening filter, ion
chamber, and mirror. The DPM MC code is used for the
patient-dependent calculation, i.e., the MLC, jaws and
patient.59 As described in a previous publication.59 the MLC
leaf model accounts for details in the MLC design, such as a
single focus, tongue-and-groove geometry, the rounded leaf
tip the and the air spaces between adjacent leaves. The model
has been benchmarked against measurements under a variety
of circumstances and been shown to be in good agreement
with measurements under stringent test conditions, such as
the closed leaf leakage patterns.59
E. Phantom Studies and Simulations
In this section, the phantom configuration and IMRT
beams used are described, followed by a brief description of
the programmable translation stage and motion profiles used
during measurements. This is followed by a description of
the analysis used for film measurements and synchronized
dynamic dose reconstruction SDDR simulation results, and
the methods used for determining uncertainties.
1. Phantom configuration
To demonstrate the concept of the SDDR method, mea-
surements were conducted and compared to simulations. In
these measurements, 14 clinical IMRT beams from two pa-
tients on a urethral sparing protocol were delivered to sta-
tionary and moving Solid Water slab phantoms. Measure-
ments were made with film at 5 cm depth in a 1540
40 cm3 Solid Water phantom with an source to surface
distance SSD of 95 cm. Kodak, XV, redipak film, was cho-
sen because the dynamic range of the film was well suited to
the range of beamlet doses, between 5 and 100 cGy, found in
these urethural-sparing prostate IMRT fields. All fields were
measured individually and found to be within the dynamic
range of the XV film. All films were from a single production
batch. Absolute dosimetry was determined by measuring an
H&D curve at 16 doses spanning the dynamic range of the
film under standard reference conditions 10 cm10 cm
field at 10 cm depth, 90 cm SSD in a 30 cm30 cm
20 cm water equivalent phantom.
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The phantom was placed on a programmable translation
stage driven by a servo motor with feedback capable of
reproducing arbitrary motion profiles with =0.05 cm aver-
age positional error for amplitudes up to 6 cm, velocities up
to 8 cm/s, and accelerations up to 10 cm/s2 with a phantom
up to 25 Kg.61 Motion is synchronized to within 2 ms of the
beginning of the beam by triggering an input/output port on
the motion controller using a modified signal from the beam
target in the accelerator.
In addition to film measurements in stationary phantoms,
measurements were made with the phantom following two
different motion profiles. The first profile is a typical ideal-
ized cosine function with the form
xt = cos4t/4 , 1
which has a 1 cm peak-to-peak amplitude and a 4 s period.
The second motion profile was the clinically measured
inferior-superior motion of the prostate, as shown in Fig.
1b, as measured with the Calypso system. This profile will
be referred to as the measured motion, and indicated with a
subscript “m”, in film measurements, Fm, and simulation re-
sults, Sm. The SDDR method was used to simulate the de-
livered dose in the plane of the film for the stationary and
clinically measured motions, while standard Monte Carlo
fluence convolution dose calculation was used to estimate
dose to the film plane for measurements with the idealized
breathing motion.
3. Analysis of film and simulation results
The measured and simulated planar dose distributions
were then compared as described below to characterize the
difference between static dose distributions, synchronized
dynamic dose distributions with measured patient motion,
and fluence convolution with idealized patient motion. Film
measurements were spatially calibrated using a Lucite tem-
plate with pinholes placed at ±11 cm longitudinally and
±12 cm laterally. The template was positioned on the film to
coincide with the cross hairs of the light field, and pin holes
were then made in the film. The films were digitized and the
pinholes used to set the spatial scale, correct film rotations,
and set isocenter coordinates. The images were then interpo-
lated bilinearly to a common grid and subtracted. This tech-
nique was used to compare dose distributions that were not
expected to be identical static vs moving distributions. A
second method was used to compare dose distributions that
were expected to be the same. In this method, the film mea-
surements were cropped to eliminate the pin holes, and an
image registration algorithm62 run to find the relative spatial
alignment including translations and rotations that mini-
mized the root-mean-square rms of the dose differences.
Variations between compared dose distributions were
quantified by finding the mean and standard deviation of the
differences in the smallest rectangular area around the dose
difference distribution that excluded only background values
as shown in Fig. 3g. Consequently, the area of the rect-
angle for image registration may have been larger than the
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measurement was made in a moving phantom.
Table I summarizes the dose distributions, D1 and D2, that
were compared D=D1−D2. Simulations in moving phan-
toms Sm, simulation of dose delivered with phantom mov-
ing with the Calypso measured clinical motion profile, Sc,
simulation of dose delivered with phantom moving under
idealized cosine motion given in Eq. 1 were compared to
the simulation in a static phantom, Ss. Film measurements in
moving phantoms, Fm and Fc, respectively, were compared
to the first film measurement in a static phantom, Fs. Simu-
lations were compared to the corresponding film measure-
ments, and repeat films of static beams, Fs2 and Fs3, were
compared to estimate uncertainties due to alignment tech-
nique and film measurements.
F. Determination of uncertainties
In the phantom studies simulated here, sufficient histories
were run such that the typical uncertainty within the field
was 1.4% at the maximum dose point, and was better than
2% in the average dose to the volume receiving greater than
50% of the maximum dose.
To estimate the uncertainties associated with the film
measurements, all seven beams of one of the two cases were
measured in a static phantom three times: twice on the same
treatment machine and again on a second machine. In addi-
tion, film measurements involving motion were repeated
twice for each of the seven beams in one of the two cases.
Static films 1, 2, and 3 for each beam were then compared to
each other using both alignment techniques to quantify the
uncertainties associated with each technique.
III. RESULTS
In this section, we first present comparisons between
SDDR simulations and film measurement undergoing the
same motion. This is followed by the measured and recon-
structed dosimetric differences between a static phantom and
a moving phantom. The uncertainties due to film measure-
ments, alignment techniques and simulation results are then
presented.
A. SDDR simulations versus film measurements
A set of sample comparisons is shown first for one beam,
then followed by the results of all comparisons in tabular
form. Figures 3a–3c show the Monte Carlo simulations in
the static phantom, and the phantom moving with a cosine
function and clinically measured motions in the top row, re-
spectively. The second row, Figs. 3d–3f, shows the corre-
sponding film measurements, while the third row, Figs.
3g–3i, shows the difference between simulations and
films. The mean and standard deviations of the differences
are also shown on the difference image. The mean and stan-
dard deviations for all SDDR-to-film comparisons are shown
in columns 1–3 SDDR vs film of Table II case 1, and
Table III case 2, for static, s, cosine, c, and measured, m,
motion profiles. In general, all average difference values
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tion profile, since the same dose is delivered to the two dis-
tributions being compared.
The average value of all 21 dosimetric differences be-
tween films and simulations in columns 1–3 seven beams,
each measured and simulated in static, cosine, and clinically
measured motion profiles for case 1 is 0.01 cGy, while for
case 2 it is 0.88 cGy, indicating very good agreement be-
tween the measured and simulated absolute doses. The stan-
dard deviation of differences between the measured distribu-
tions and the simulated distributions is typically 3–4 cGy in
FIG. 3. Monte Carlo simulations in the static phantom, and the phantom mo
row. The second row shows the corresponding film measurements, while th
standard deviations of the differences are also shown for the smallest rectangu
left.both static and moving phantoms. While the typical differ-
Medical Physics, Vol. 34, No. 1, January 2007ence is generally 2  cGy across the field, the standard de-
viation is strongly influenced by small areas of disagreement
at leaf edges.
B. Simulated and measured deviations from static
dose distributions
In clinical practice, the difference between a statically
planned and delivered case, versus the dose distribution ac-
tually received in the presence of motion, is the primary
concern. The dose differences caused by idealized cosine
with a cosine function Eq. 1 and clinically measured motions in the top
rd row shows the difference between simulations and films. The mean and
gion containing dose differences above background, as shown in the bottomving
e thi
lar remotion, compared to a static phantom, are shown in Fig. 4a
97 Litzenberg et al.: Synchronized dynamic dose reconstruction 97SDDR and Fig. 4c film measurement. The dose differ-
ences caused by the clinically measured motion, compared to
a static phantom, are shown in Fig. 4b SDDR and Fig.
4d film measurement. The mean and standard deviations
TABLE I. Illustration of comparisons D=D1−D2, where the first letter
denotes simulation, S, or film measurement, F, and the second letter denotes
either static phantom, s, a phantom moving with a cosine motion, c, or a
phantom moving with a clinically measured motion, m. Static films were
measured three times on two machines, while motion measurements were
made twice each on the same machine.
TABLE II. Average and standard deviations for all comparisons in case 1. D
for static, s, cosine, c, and measured, m, motion profiles. Columns 4 and 5 s
cosine minus static film 1, and measured minus static film 1, and the corre
show the differences between repeat films for all beams and motion cases u
are shown in columns 11–13 for a pinhole-based transformation. Columns 14
with different alignment techniques.
Average di
Column 1 2 3 4 5 6 7 8
SDDR vs Film Motion vs Static
Beam s c m Fc-Fs1 Fm-Fs1 Sc-Ss Sm-Ss s
1 0.10 −0.42 0.31 0.72 0.83 0.37 0.23 −0.
2 0.44 −0.64 −0.04 0.85 0.32 −0.17 −0.12 −0.
3 −0.67 −1.10 −0.72 0.45 0.30 −0.03 0.19 −0.
4 0.65 −0.47 −0.25 1.14 0.78 −0.02 −0.04 −0.
5 0.87 0.22 −0.61 0.39 1.45 −0.18 0.10 −0.
6 0.66 0.26 0.04 0.43 0.84 0.20 0.22 −0.
7 1.00 0.29 0.12 0.62 0.87 −0.05 0.05 −0.
ave 0.44 −0.27 −0.16 0.66 0.77 0.02 0.09 −0.
Standard Deviatio
Column 1 2 3 4 5 6 7 8
SDDR vs Film Motion vs Static
Beam s c m Fc-Fs1 Fm-Fs1 Sc-Ss Sm-Ss s
1 3.61 2.62 3.91 17.66 11.72 18.75 9.95 1.9
2 3.78 2.91 3.80 19.82 9.06 19.59 9.40 1.5
3 3.82 3.65 3.52 20.31 10.38 17.96 8.94 1.7
4 3.38 2.95 3.59 16.36 9.57 17.32 7.98 1.5
5 3.68 3.27 4.34 18.99 10.15 17.54 9.44 1.5
6 3.21 2.89 3.34 18.95 10.88 17.51 9.42 1.9
7 3.52 2.85 3.65 19.20 10.49 19.67 11.35 1.6
RMS  3.58 3.04 3.75 18.80 10.35 18.36 9.55 1.7Medical Physics, Vol. 34, No. 1, January 2007for each of the seven beams are summarized in columns four
and five of Tables II and III, for film measurements cosine
minus static, and measured minus static, and in columns six
and seven for SDDR reconstructions. The average value of
differences between static and moving films is about
0.7 cGy, while it is only 0.03 cGy for simulation compari-
sons. The standard deviation of differences between cosine
and static motions was 18.80 and 18.36 cGy for film and
SDDR reconstructions, respectively, while between clinically
measured and static motions they were 10.35 and 9.55 cGy
for film and SDDR reconstructions, respectively. Note that
the simulation results are expected to have perfect registra-
tion, and therefore lower standard deviations of the differ-
ences.
C. Uncertainty due to film alignment technique
To compare the above dose distributions between moving
and static phantoms, the films must be spatially calibrated
using the pinholes made in the film. Image registration can-
not be used here, as it was for the comparisons in Fig. 3,
because the different motion profiles make the dose distribu-
tions different. This leads to slight misalignments, resulting
nces between SDDR and film are shown in columns 1–3 SDDR vs Film,
differences between moving and static phantoms for film measurements, F,
ding SDDR comparisons, S, are shown in columns 6 and 7. Columns 8–10
an intensity-based image registration technique, while the same differences
how differences between repeat static films measured on different machines
ces cGy
9 10 11 12 13 14 15 16 17
F2-F1R F2-F1T Fs3-Fs1 Fs3-Fs2
c m s c m R T R T
−0.38 0.15 −0.67 −0.40 0.12 1.86 1.90 1.22 −1.26
−0.31 0.33 −0.33 −0.31 0.34 0.59 0.54 0.86 0.86
−0.36 −0.15 −0.78 −0.36 −0.21 0.06 0.04 0.81 0.79
−0.33 −0.51 −0.10 −0.38 −0.54 0.55 0.48 0.60 0.58
−0.49 −1.19 −0.62 −0.48 −1.17 −0.05 −0.10 0.58 0.52
−0.71 −0.11 −0.18 −0.68 −0.19 0.15 0.58 0.73 0.74
−0.51 −0.28 −0.71 −0.51 −0.30 1.24 1.22 1.98 1.96
−0.44 −0.25 −0.49 −0.45 −0.28 0.63 0.67 0.97 0.60
Differences (cGy)
9 10 11 12 13 14 15 16 17
2-F1R F2-F1T Fs3-Fs1 Fs3-Fs2
c m s c m R T R T
1.05 1.42 4.53 2.05 2.84 2.15 2.60 1.24 4.30
1.01 2.37 5.74 2.39 4.13 1.40 6.99 1.77 6.18
1.05 1.10 9.09 5.18 6.91 0.94 14.75 1.66 10.83
1.38 0.96 5.52 4.15 4.02 1.25 7.06 1.28 4.73
1.60 1.20 7.15 4.28 7.68 1.13 4.71 1.09 4.38
1.28 0.95 6.26 2.58 4.99 1.94 5.75 1.61 2.07
0.89 1.25 4.07 1.57 3.19 1.55 4.54 1.07 1.80
1.20 1.40 6.25 3.41 5.12 1.53 7.55 1.41 4.90iffere
how
spon
sing
–17 s
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67
30
77
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62
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74
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Medical Physics, Vol. 34, No. 1, January 2007in larger dose differences than typically observed when using
intensity based image registration. To characterize the differ-
ences between these two registration techniques, repeat film
measurements were aligned using both techniques. Figure 5
shows the typical difference between two static films of the
same beam that were aligned using both pinholes from a
template and image registration. The mean and standard de-
viation of the differences between film 2 and film 1, using
the intensity-based registration technique, are shown in col-
umns 8–10 of Table II, while the same results using the
pinhole based transformation are shown in columns 11–13.
The average differences are all about −0.4 cGy regardless of
registration technique or motion profile. However, the stan-
dard deviations for the image registration technique range
between 1.2 and 1.71 cGy, depending on the motion profile,
while for the pinhole transformation technique they range
between 3.41 and 6.25 cGy. The standard deviations within
each registration technique increase from cosine motion, to
clinically measured to static motions, as would be expected
as the distributions become less blurred by the motion. If we
assume that the standard deviation of the pinhole registration
is the quadratic sum of an intensity-based component, quan-
tified by the image registration technique and a
misalignment-based component, we see that the variations
due to small misalignments dominate over intensity-based
differences.
D. Uncertainty in SDDR Monte Carlo simulations
Figure 6 shows the uncertainty in the simulation of a
static phantom. Uncertainties within the field range between
FIG. 4. The difference between each motion case and
the static case, for both films and simulations.TABLE III. Average and standard deviations for all comparisons in case 2.
Average Differences cGy
Column 1 2 3 4 5 6 7
SDDR vs Film Motion vs Static
Beam s c m Fc-Fs1 Fm-Fs1 Sc-Ss Sm-Ss
8 0.56 0.31 −0.44 0.41 1.23 −0.01 0.17
9 1.55 0.97 0.21 0.56 1.32 0.04 0.09
10 1.80 0.79 0.64 0.53 0.87 −0.12 −0.09
11 1.07 0.76 −0.14 0.33 1.19 0.17 0.04
12 1.71 0.83 −0.16 0.59 1.65 −0.12 −0.12
13 2.78 1.91 0.22 0.76 2.42 0.12 −0.01
14 2.21 1.01 −0.13 0.97 2.09 −0.01 −0.14
ave 1.67 0.94 0.03 0.59 1.54 0.01 −0.01
Standard Deviation of Differences (cGy)
Column 1 2 3 4 5 6 7
SDDR vs Film Motion vs Static
Beam s c m Fc-Fs1 Fm-Fs1 Sc-Ss Sm-Ss
ave 1.67 0.94 0.03 0.59 1.54 0.01 −0.01
8 2.60 2.40 3.10 14.32 8.34 13.43 6.85
9 3.63 2.72 3.17 16.02 9.45 7.38 19.95
10 3.47 2.78 3.46 16.52 11.90 17.00 11.22
11 3.25 2.42 3.30 16.33 8.01 16.44 8.28
12 3.24 2.41 3.15 12.38 10.64 15.92 7.98
13 4.24 3.54 3.97 18.69 8.68 18.94 9.80
14 3.57 3.06 3.52 17.10 9.42 18.36 8.83
RMS  3.46 2.79 3.39 16.02 9.57 15.78 11.19
99 Litzenberg et al.: Synchronized dynamic dose reconstruction 991.4% and 2.0% of the maximum dose, which corresponds to
roughly 1.2–1.8 cGy. This is comparable to the standard de-
viation of differences found between repeat film measure-
ments 1.2–1.7 cGy for all seven beams and all three mo-
tion profiles in case 1 when using intensity-based image
registration.
IV. DISCUSSION
In this section, the agreement between the film measure-
ments and the simulations is discussed first, followed by the
magnitude of the dosimetric errors due to motion as quanti-
fied by measurements and simulations. The uncertainty in the
results is discussed based on repeated film measurements and
the registration technique used for making comparisons. And
finally, the applicability of the method in nonrigid patient
geometries is discussed.
A. Comparison of film measurements and
simulations
As seen in Fig. 3, the measured and simulated dose dis-
tributions in static phantoms, and phantoms moving with the
cosine function Eq. 1 and clinically measured motion pro-
files, are generally well reproduced by the SDDA method.
Features of the dose distributions measured with film are also
FIG. 6. The uncertainty 100 /mean in the simulation of dose delivered to
a static phantom. The percent relative uncertainties in dose were, on aver-
age, within 2% of the exposed region for all simulations in this study.
Medical Physics, Vol. 34, No. 1, January 2007seen in the simulations, such as tongue-and-groove effect
and the interplay between leaf motion and target volume mo-
tion. These differences may be due to many factors, which
include deviations in the MLC model compared to the physi-
cal design, uncertainties in spatial registration of the simula-
tion and film, film processing and digitization, and over re-
sponse of the film to lower energy scattered radiation.
B. Dosimetric errors due to motion
The magnitude and location of dosimetric errors due to
motion depends on several factors. These included the am-
plitude and temporal characteristics of the target volume mo-
tion profile, the complexity of the fluence distribution, which
determines the trajectories of each leaf pair, whether the
beam is delivered with dynamic or step-and-shoot IMRT, and
the ability of the MLC to deliver the leaf sequence. The
largest errors both in magnitude and in spatial extent occur
just outside the fluence pattern along the direction of motion,
with lateral dimensions in the beam’s eye view that are de-
fined by the width of the beam and the range of target vol-
ume motion. The magnitude of these errors may be of any
size but tend to be large due too beamlets which are prefer-
entially optimized to create large gradients at clinically im-
portant anatomical or biological boundaries. These types of
errors are shown in Fig. 4, where dose distributions in mov-
ing phantoms have been compared to those in static phan-
toms. Similarly, regions intended to receive low dose may
move into adjacent high-fluence beamlets. The volume and
magnitude of these errors tend to be lower than those outside
of the fluence pattern. Likewise, regions of high dose may
receive more or less dose due to motion along local dose
gradients.
Parts of the target volume that are under smooth regions
of the fluence pattern are typically expected to receive the
expected dose regardless of motion. However, as seen in the
measurements and simulations of IMRT fields delivered to
phantoms under clinically measured motions Fig. 3, such
regions with low dose gradients may be delivered at different
times due to differing dose modulation under adjacent leaf
pairs earlier in the delivery. Consequently, temporal interplay
among adjacent leaf pairs and target volume motion may
FIG. 5. The typical difference between two static films
of the same beam which were aligned using both pin-
holes from a template and image registration.create sizable dose discrepancies even in areas of a fluence
100 Litzenberg et al.: Synchronized dynamic dose reconstruction 100pattern with no dose gradient. Such temporal interplay ef-
fects are seen to create average hot spots of +12% with a
lateral extent of 0.5 cm6 cm in Figs. 4b and 4d near
the top of the field, with a corresponding cold spot below it.
These types of dosimetric errors are not seen in the dose
distributions delivered with the idealized cosine motion.
Such features of the delivered dose distribution are well
reproduced by the SDDR method as characterized by the
similar standard deviations Tables II and III and Fig. 7 for
simulations of film measurements. Comparisons of films to
simulations show standard deviations of 3–4 cGy with rela-
tively little variation based on motion. As a base line for
comparison of standard deviation values, repeat films in
static and moving phantoms were measured on the same ma-
chine for all beams in case 1. These dose distributions were
registered and the differences show a standard deviation of
about 1.5 cGy, while alignment with the template gives
much larger standard deviations of about 5 cGy. Conse-
quently, simulation to film agreement is seen to be better
than repeat film measurements when spatially aligned with
0.1 cm accuracy.
C. Dosimetric uncertainty due to system latencies
The real-time tracking methods for the MLC and the tar-
get volume are subject to system latencies that contribute to
the dosimetric uncertainty. The latency in the Varian Dyna-
Log files is known to be about 0.05 s.9,45,63 The Calypso
system makes measurements at 10 Hz giving a worst case
latency time of 0.1 s.64 In our clinic, IMRT treatments are
delivered at a dose rate of 400 MU/min, and 1 MU is cali-
brated to be 0.8 cGy at 10 cm depth in 1010 cm2 field
with an SSD of 90 cm. Consequently, the dosimetric uncer-
tainty due to system latencies may be estimated to be
D 
0.8 cGy
MU 400 MUmin 1 min60 s 0.05 + 0.1 s = 0.8 cGy,
2
which, in the worst case, is still less than 1% of the maxi-
mum dose in each beam.
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The experiments presented here were conducted in rigid,
nondeforming water-equivalent phantoms where the position
of each volume element was known with high positional
accuracy dx0.05 cm, at any given time dt0.01 s. In
clinical practice, the accuracy of this technique will be lim-
ited by the spatial and temporal accuracy of the four-
dimensional 4D patient model used in the SDDR method.
The level of spatial accuracy required to realize a potential
therapeutic gain might vary throughout the model, though at
critical boundaries they would certainly need to be less than
the planning target volume margins used in treatment plan-
ning. As new imaging and tracking technologies are intro-
duced in the treatment room, more accurate 4D patient data
will become available as input for this method. Similar to
treatment planning methods that seek to account for motion,
the simplest implementation of a 4D patient model would
simply shift the planning CT based on real-time target vol-
ume tracking techniques. The next more sophisticated patient
model would simply use daily CBCT data to create a de-
formed model of the patient that is then rigidly translated
using real-time target volume tracking data. In the future,
more accurate 4D models may be created using real-time
surface tracking, fluoroscopy, and electromagnetic tracking
to deform CBCT data in real time. Spatial accuracy would
then likely depend on the accuracy of future deformable im-
age mapping models or finite element modeling methods. As
in-room imaging and tracking technologies evolve, along
with deformable image registration methods and computer
speed, it remains to be seen how accurate and practical 4D
data-driven patient models become over time. In addition, to
assess the clinical value of this work, the dose will have to be
accumulated over the entire course of treatment and its value
for modifying treatment plans and treatment delivery as-
sessed versus the effort and cost of implementing the SDDR
method at the required level of accuracy.
V. CONCLUSIONS
These results indicate that the synchronized dynamic dose
FIG. 7. Summary of average values
from each column of Tables I and II.
Comparisons shown with an “X” rep-
resents the average dose difference for
case 1, from Table I, while data shown
in bold and with diamonds represents
average dose difference for case 2,
from Table II. Standard deviations
±1 s are represented by the error
bars.reconstruction method is capable of combining real-time tar-
101 Litzenberg et al.: Synchronized dynamic dose reconstruction 101get volume motion data and real-time machine configuration
data to reproduce delivered dose distributions within the
measurement and simulation uncertainties in the rigid phan-
tom geometries considered here. The average discrepancy
between film measurement and simulations is less than
1 cGy, and the large deviations created by effects such as
MLC and target volume motion interplay, and tongue-and-
groove effect, are reproduced spatially and dosimetrically.
The standard deviations of these large differences agree also
agree within 1 cGy. This is made possible through temporal
synchronization of the machine fluence and motion profiles,
currently available in the Varian DynaLog files, with real-
time target volume motion profiles. In the future, we plan to
conduct studies to correlate accumulated dose in prostate pa-
tients with clinical outcomes to verify clinical usefulness of
the synchronized dynamic dose reconstruction method. As
in-room image guidance and real-time tracking technologies
advance in the coming years, along with deformable image
mapping, this technique may prove to provide therapeutic
benefit in dynamic refinement and delivery of a patient’s
therapy.
ACKNOWLEDGMENTS
N.T. and I.J.C. are supported in part by Grant No. R01-
CA106770 from the NIH NCI. This work was also sup-
ported in part by Grant No. 1PO1CA59827-01 from the NCI.
aAuthor to whom correspondence should be addressed; electronic mail:
litzen@umich.edu
1C. X. Yu, D. A. Jaffray, and J. W. Wong, “The effects of intra-fraction
organ motion on the delivery of dynamic intensity modulation,” Phys.
Med. Biol. 431, 91–104 1998.
2P. J. Keall, V. R. Kini, S. S. Vedam, and R. Mohan, “Motion adaptive
x-ray therapy: A feasibility study,” Phys. Med. Biol. 46, 1–10 2001.
3S. B. Jiang, C. Pope, K. M. Al Jarrah, J. H. Kung, T. Bortfeld, and G. T.
Chen, “An experimental investigation on intra-fractional organ motion
effects in lung IMRT treatments,” Phys. Med. Biol. 4812, 1773–1784
2003.
4T. R. Bortfeld, D. L. Kahler, T. J. Waldron, and A. L. Boyer, “X-ray field
compensation with multileaf collimators,” Int. J. Radiat. Oncol., Biol.,
Phys. 283, 723–730 1994.
5S. M. Crooks, L. F. McAven, D. F. Robinson, and L. Xing, “Minimizing
delivery time and monitor units in statis IMRT by leaf-sequencing,” Phys.
Med. Biol. 47, 3105–3116 2003.
6M. L. Dirkx, B. J. Heijmen, and J. P. van Santvoort, “Leaf trajectory
calculation for dynamic multileaf collimation to realize optimized fluence
profiles,” Phys. Med. Biol. 435, 1171–1184 1998.
7S. Kamath, S. Sahni, J. Palta, and S. Ranka, “Algorithms for optimal
sequencing of dynamic multileaf collimators,” Phys. Med. Biol. 49,
33–54 2004.
8M. Langer, V. Thai, and L. Papiez, “Improved leaf sequencing reduces
segments or monitor units needed to delivery IMRT using multileaf col-
limators,” Med. Phys. 2812, 2450–2458 2001.
9D. W. Litzenberg, J. M. Moran, and B. A. Fraass, “Incorporation of real-
istic delivery limitations into dynamic MLC treatment delivery,” Med.
Phys. 295, 810–820 2002.
10L. Ma, A. L. Boyer, L. Xing, and C. M. Ma, “An optimized leaf-setting
algorithm for beam intensity modulation using dynamic multileaf colli-
mators,” Phys. Med. Biol. 436, 1629–1643 1998.
11C. B. Saw, R. A. C. Siochi, K. M. Ayyangar, W. Zhen, and C. A. Enke,
“Leaf sequencing techniques for MLC-based IMRT,” Med. Dosim 262,
199–204 2001.
12J. P. van Santvoort and B. J. Heijmen, “Dynamic multileaf collimation
without ‘tongue-and-groove’ underdosage effects,” Phys. Med. Biol.
4110, 2091–2105 1996.
Medical Physics, Vol. 34, No. 1, January 200713P. Xia and L. Verhey, “Multileaf collimator leaf sequencing algorithm for
intensity modulated beams with multiple static segments,” Med. Phys.
258, 1424–1434 1998.
14Y. Yang and L. Xing, “Incorporating leaf transmission and head scatter
corrections into step-and-shoot leaf sequences for IMRT,” Int. J. Radiat.
Oncol., Biol., Phys. 554, 1121–1134 2003.
15W. Que, J. Kung, and J. Dai, “‘Tongue-and-groove’ effect in intensity
modulated radiotherapy with static multileaf collimator fields,” Phys.
Med. Biol. 493, 399–405 2004.
16S. Kamath, S. Sahni, S. Ranka, J. Li, and J. Palta, “A comparison of
step-and-shoot leaf sequencing algorithms that eliminate tongue-and-
groove effects,” Phys. Med. Biol. 4914, 3137–3143 2004.
17S. Kamath, S. Sahni, J. Palta, S. Ranka, and J. Li, “Optimal leaf sequenc-
ing with elimination of tongue-and-groove underdosage,” Phys. Med.
Biol. 493, 7–19 2004.
18D. Jianrong and W. Que, “Simultaneous minimization of leaf travel dis-
tance and tongue-and-groove effect for segmental intensity-modulated ra-
diation therapy,” Phys. Med. Biol. 4923, 5319–5331 2004.
19F. Haryanto, M. Fippel, A. Bakai, and F. Nusslin, “Study on the tongue
and groove effect of the Elekta multileaf collimator using Monte Carlo
simulation and film dosimetry,” Strahlenther. Onkol. 1801, 57–61
2004.
20T. LoSasso, C.-S. Chui, and C. C. Ling, “Comprehensive quality assur-
ance for the delivery of intensity modulated radiotherapy with a multileaf
collimator used in the dynamic mode,” Med. Phys. 2811, 2209–2219
2001.
21G. A. Ezzell and S. Chungbin, “The overshoot phenomenon in step-and-
shoot IMRT delivery,” J. Appl. Clin. Med. Phys. 23, 138–148 2001.
22P. Xia, C. F. Chuang, and L. J. Verhey, “Communication and sampling
rate limitations in IMRT delivery with a dynamic multileaf collimator
system,” Med. Phys. 293, 412–423 2002.
23L. Ma, P. B. Geis, and A. L. Boyer, “Quality assurance for dynamic
multileaf collimator modulated fields using a fast beam imaging system,”
Med. Phys. 248, 1213–1220 1997.
24J. Sonke, J. M. Balter, M. van Herk, L. Zijp, M. L. Kessler, and R.
Kashani, “Recalculation of dose changes due to breathing movement as-
sessed from respiratory-correlated cone beam CT,” Int. J. Radiat. Oncol.,
Biol., Phys. 60s1, S289 2004.
25B. Schaly, G. S. Bauman, J. J. Battista, and J. V. Dyk, “Validation of
contour-driven thin-plate splines for tracking fraction-to-fraction changes
in anatomy and radiation therapy dose mapping,” Phys. Med. Biol. 50,
459–475 2005.
26J. M. Balter, K. L. Lam, C. J. McGinn, T. S. Lawrence, and R. K. Ten
Haken, “Improvement of CT-based treatment-planning models of ab-
dominal targets using static exhale imaging,” Int. J. Radiat. Oncol., Biol.,
Phys. 414, 939–943 1998.
27I. J. Chetty, M. Rosu, D. L. McShan, B. A. Fraass, J. M. Balter, and R. K.
Ten Haken, “Accounting for center-of-mass target motion using convolu-
tion methods in Monte Carlo-based dose calculations of the lung,” Med.
Phys. 314, 925–932 2004.
28I. J. Chetty, M. Rosu, N. Tyagi, L. H. Marsh, D. L. McShan, J. M. Balter,
B. A. Fraass, and R. K. Ten Haken, “A fluence convolution method to
account for respiratory motion in three-dimensional dose calculations of
the liver: A Monte Carlo study,” Med. Phys. 307, 1776–1780 2003.
29P. Giraud, Y. De Rycke, B. Dubray, S. Helfre, D. Voican, L. Guo, J. C.
Rosenwald, K. Keraudy, M. Housset, E. Touboul, and J. M. Cosset,
“Conformal radiotherapy CRT planning for lung cancer: Analysis of
intrathoracic organ motion during extreme phases of breathing,” Int. J.
Radiat. Oncol., Biol., Phys. 514, 1081–1092 2001.
30P. J. Keall, J. V. Siebers, S. Joshi, and R. Mohan, “Monte Carlo as a
four-dimensional radiotherapy treatment-planning tool to account for res-
piratory motion,” Phys. Med. Biol. 4916, 3639–3648 2004.
31J. Li and L. Xing, “Inverse planning incorporating organ motion,” Med.
Phys. 277, 1573–1578 2000.
32D. M. Lockman, D. Yan, and J. Wong, “Estimating the dose variation in
a volume of interest with explicit consideration of patient geometric
variation,” Med. Phys. 279, 2100–2108 2000.
33A. E. Lujan, J. M. Balter, and R. K. Ten Haken, “A method for incorpo-
rating organ motion due to breathing into 3D dose calculations in the
liver: Sensitivity to variations in motion,” Med. Phys. 3010, 2643–2649
2003.
34T. Bortfeld, K. Jokivarsi, M. Goitein, J. Kung, and S. B. Jiang, “Effects of
intra-fraction motion on IMRT dose delivery: Statistical analysis and
102 Litzenberg et al.: Synchronized dynamic dose reconstruction 102simulation,” Phys. Med. Biol. 4713, 2203–2220 2002.
35I. J. Chetty, K. L. Lam, J. M. Balter, R. K. Ten Haken, D. L. McShan, and
H. M. Sandler, “Dosimetric implications of approximating setup uncer-
tainties with Gaussian distributions in Monte Carlo based prostate cancer
treatment planning,” Radiother. Oncol. submitted 2005.
36I. J. Chetty, M. Rosu, D. L. McShan, B. A. Fraass, and R. K. Ten Haken,
“Inverse plan optimization incorporating random setup uncertainties us-
ing Monte Carlo based fluence convolution,” Int. J. Radiat. Oncol., Biol.,
Phys. submitted 2005.
37T. R. Mackie, J. W. Scrimger, and J. J. Battista, “A convolution method of
calculating dose for 15 MV x rays,” Med. Phys. 122, 188–196 1985.
38R. George, S. S. Vedam, T. D. Chung, V. Ramakrishnan, and P. J. Keall,
“The application of the sinusoidal model to lung cancer patient respira-
tory motion,” Med. Phys. 329, 2850–2861 2005.
39S. Webb, “The effect on IMRT conformality of elastic tissue movement
and a practical suggestion for movement compensation via the modified
dynamic multileaf collimator dMLC technique,” Phys. Med. Biol.
506, 1163–1190 2005.
40S. Webb, “Motion effects in intensity modulated radiation therapy: A
review,” Phys. Med. Biol. 5113, R403–R425 2006.
41L. Papiez, D. Rangaraj, and P. Keall, “Real-time DMLC IMRT delivery
for mobile and deforming targets,” Med. Phys. 329, 3037–3048 2005.
42C. S. Chui, E. Yorke, and L. Hong, “The effects of intra-fraction organ
motion on the delivery of intensity-modulated field with a multileaf col-
limator,” Med. Phys. 307, 1736–1746 2003.
43S. A. Naqvi and W. D. D’Souza, “A stochastic convolution/superposition
method with isocenter sampling to evaluate intrafraction motion effects in
IMRT,” Med. Phys. 324, 1156–1163 2005.
44D. W. Litzenberg, J. M. Moran, and B. A. Fraass, “Verification of dy-
namic and segmental IMRT delivery by dynamic log file analysis,” J.
Appl. Clin. Med. Phys. 32, 63–72 2002.
45A. M. Stell, J. G. Li, O. A. Zeidan, and J. F. Dempsey, “An extensive
log-file analysis of step-and-shoot intensity modulated radiation therapy
segment delivery errors,” Med. Phys. 316, 1593–1602 2004.
46J. G. Li, J. F. Dempsey, L. Ding, C. Liu, and J. R. Palta, “Validation of
dynamic MLC-controller log files using a two-dimensional diode array,”
Med. Phys. 305, 799–805 2003.
47O. A. Zeidan, J. G. Li, M. Ranade, A. M. Snell, and J. F. Dempsey,
“Verification of step-and-shoot IMRT delivery using a fast video-based
electronic portal imaging device,” Med. Phys. 313, 463–476 2004.
48P. Zygmanski, J. H. Kung, S. B. Jiang, and L. Chin, “Dependence of
fluence errors in dynamic IMRT on leaf-positional errors varying with
time and leaf number,” Med. Phys. 3010, 2736–2749 2003.
49J. M. Balter, S. Hadley, D. Litzenberg, H. Sandler, E. Vertatschitsch, S.
Dimmer, T. Willoughby, and P. Kupelian, “Accuracy of a 4D magnetic
localization system: Evaluation in the clinical environment,” Int. J. Ra-
diat. Oncol., Biol., Phys. 601 Supplement, S612–S613 2004.
50T. Willoughby, P. Kupelian, J. Pouliot, K. Shinohara, M. Aubin, M.
RoachIII, L. Skrumeda, J. Balter, D. Litzenberg, S. Hadley, J. Wei, and H.
Sandler, “Implant experience and positional stability of AC magnetic bea-
contm transponders used to localize patients for external beam radiation
therapy of the prostate,” Int. J. Radiat. Oncol., Biol., Phys. 60Suppl 1,
Medical Physics, Vol. 34, No. 1, January 2007S267–S268 2004.
51D. W. Litzenberg, J. M. Balter, S. W. Hadley, H. M. Sandler, T. R.
Willoughby, P. A. Kupelian, and L. Levine, “The influence of intra-
fraction motion on margins for prostate radiotherapy,” Int. J. Radiat. On-
col., Biol., Phys. 652, 548–553 2006.
52J. Sempau, S. J. Wilderman, and A. F. Bielajew, “DPM, a fast, accurate
Monte Carlo code optimized for photon and electron radiotherapy treat-
ment planning dose calculations,” Phys. Med. Biol. 24, 2263–2291
2000.
53I. J. Chetty, P. M. Charland, N. Tyagi, D. L. McShan, B. A. Fraass, and A.
F. Bielajew, “Photon beam relative dose validation of the DPM Monte
Carlo code in lung-equivalent media,” Med. Phys. 304, 563–573
2003.
54I. J. Chetty, J. J. DeMarco, and T. D. Solberg, “A virtual source model for
Monte Carlo modeling of arbitrary intensity distributions,” Med. Phys.
271, 166–172 2000.
55I. J. Chetty, J. M. Moran, D. L. McShan, B. A. Fraass, S. J. Wilderman,
and A. F. Bielajew, “Benchmarking of the Dose Planning Method DPM
Monte Carlo code using electron beams from a racetrack microtron,”
Med. Phys. 296, 1035–1041 2002.
56N. Tyagi, I. J. Chetty, B. A. Fraass, and A. F. Bielajew, “Calculations of
a Millennium Multileaf Collimator using the DPM and BEAM/DOSXYZ
Monte Carlo codes,” Med. Phys. 296, 1230 2002.
57I. J. Chetty, N. Tyagi, M. Rosu, P. M. Charland, D. L. McShan, R. K. Ten
Haken, B. A. Fraass, and A. F. Bielajew, presented at the Nuclear Math-
ematical and Computational Sciences: A Century in Review, A Century
Anew, Gatlinburg, TN, 2003 unpublished.
58M. Rosu, M. M. Coselmon, E. Acosta, B. Fraass, M. D, and I. J. Chetty,
“Implementation and initial testing of a Monte Carlo based algorithm for
IMRT inverse treatment planning,” Med. Phys. accepted.
59N. Tyagi, J. M. Moran, D. W. Litzenberg, A. F. Bielajew, B. A. Fraass,
and I. J. Chetty, “Experimental verification of a Monte Carlo-based
source model for IMRT treatment planning,” Med. Phys. accepted.
60D. W. O. Rogers, B. R. Walters, and I. Kawrakow, BEAMnrc Users
Manual: National Research Council Report PIRS-0509(A) rev. H. Ot-
tawa, Canada, 2004.
61D. W. Litzenberg, S. W. Hadley, K. L. Lam, and J. M. Balter, “A preci-
sion translation stage for reproducing measured target volume motions,”
J. Appl. Clin. Med. Phys. accepted.
62P. Thévenaz and M. Unser, “A pyramid approach to subpixel registration
based on intensity,” IEEE Trans. Image Process. 7, 27–41 1998.
63C. Burman, C. S. Chui, G. Kutcher, S. Leibel, M. Zelefsky, T. LoSasso, S.
Spirou, Q. Wu, J. Yang, J. Stein, R. Mohan, Z. Fuks, and C. C. Ling,
“Planning delivery and quality assurance of intensity-modulated radio-
therapy using dynamic multileaf collimator: A strategy for large-scale
implementation for the treatment of carcinoma of the prostate,” Int. J.
Radiat. Oncol., Biol., Phys. 394, 863–873 1997.
64J. M. Balter, J. N. Wright, L. J. Newell, B. Frieme, S. Dimmer, Y. Cheng,
J. Wong, E. Vertatschitsch, and T. P. Mate, “Accuracy of a wireless lo-
calization system for radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys.
613, 933–937 2005.
